+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Biologics Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Biologics Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 121 Pages
  • Global
From
From
From
From
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026 - Product Thumbnail Image

Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026

  • Drug Pipelines
  • January 2020
  • 1500 Pages
  • Global
From
From
From
Hidradenitis Suppurativa - Pipeline Insight, 2024 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
From
Regenerative Medicine Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Regenerative Medicine Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 139 Pages
  • Global
From
From
Cervical Spondylosis Treatment Global Market Report 2024 - Product Thumbnail Image

Cervical Spondylosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hypophosphatasia Treatment Global Market Report 2024 - Product Thumbnail Image

Hypophosphatasia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 409 Pages
  • Global
From
Loading Indicator